Psychosocial interventions for people with both severe mental illness and substance misuse (Q24197576)

2

0 references

Kirsten Morley

object named as

Kirsten Morley

3

0 references

author name string

Glenn E Hunt

1

0 references

Thiagarajan Sitharthan

4

0 references

Michelle Cleary

Cochrane Database of Systematic Reviews

5

0 references

publication date

3 October 2013

0 references

published in

0 references

cites work

Evaluation of a motivational interview for substance use within psychiatric in-patient services

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Motivational interviewing among psychiatric in-patients with substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Predicting therapeutic alliance in clients with psychosis and substance misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The challenge of treating forensic dual diagnosis clients: comment on "integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Does assertive community treatment increase medication adherence for people with co-occurring psychotic and substance use disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrating services for schizophrenia and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomize

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Test-retest reliability of the Danish Adult Reading Test in patients with comorbid psychosis and cannabis-use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cost-effectiveness of substance disorder interventions for people with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A brief motivational intervention for substance misuse in recent-onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Stop Using Stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Contingency management for patients with serious mental illness and stimulant dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Approach to treatment of mental illness and substance dependence in remote Indigenous communities: results of a mixed methods study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Contingency Management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

An integrated treatment program for dually diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The effects of motivational interviewing on patients with comorbid substance use admitted to a psychiatric emergency unit - a randomised controlled trial with two year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Group cognitive-behavioural therapy for schizophrenia. Randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Motivational intervention increases exercise in schizophrenia and co-occurring substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Treating substance abuse in schizophrenia. An initial report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Predictors of referral to Supported Employment among consumers with co-occurring mental and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Change in neurocognition by housing type and substance abuse among formerly homeless seriously mentally ill persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Managing MICA clients in a modified therapeutic community with enhanced staffing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Impact of supported housing on clinical outcomes: analysis of a randomized trial using multiple imputation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Family support and substance use outcomes for persons with mental illness and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Randomized trial of psychiatric care with representative payeeship for persons with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated care for co-occurring disorders: psychiatric symptoms, social functioning, and service costs at 18 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The efficacy of substance abuse education among dual-diagnosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Effects of diagnosis, demographic characteristics, and case management on rehospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Secondary prevention of hazardous alcohol consumption in psychiatric out-patients: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Implementing assertive community treatment teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Modified therapeutic community for mentally ill chemical abusers: outcomes and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Acute Ketamine Intoxication Treated by Haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Case management for dually diagnosed individuals involved in the criminal justice system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Effects of substance dependence on outcomes of patients in a randomized trial of two case management models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Service enhancement to a dual-diagnosis population: mental illness/substance abuse (MISA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Promising treatments for women with comorbid PTSD and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Immediate outcomes of substance use treatment within a state psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Effects of substance abuse on housing stability of homeless mentally Ill persons in supported housing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Issues and outcomes in integrated treatment programs for dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A dual diagnosis demonstration project: treatment outcomes and cost analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Residential treatment for dually diagnosed homeless veterans: a comparison of program types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Motivational interviewing with psychiatrically ill substance abusing patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Service use and cost by mentally ill chemical abusers: differences by retention in a therapeutic community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

An experimental comparison of three types of case management for homeless mentally ill persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Analysis of postdischarge change in a dual diagnosis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Rural and urban differences in patients with a dual diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Substance abuse and first-episode schizophrenia-spectrum disorders. The Danish OPUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Characteristics and Treatment of Homeless, Mentally Ill, Chemical-Abusing Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Outcomes of managing disability benefits among patients with substance dependence and severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cost-effectiveness of intensive psychiatric community care for high users of inpatient services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Modified TC for MICA offenders: crime outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Severely mentally ill substance abusers: an 18-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated drug and alcohol intervention: development of an opportunistic intervention program to reduce alcohol and other substance use among psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Evaluating use of continuous treatment teams for persons with mental illness and substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Training in dual diagnosis interventions (the COMO Study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study): cluster randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Service utilization during and after outpatient treatment for comorbid substance use disorder and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The role of twelve-step approaches in dual diagnosis treatment and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Social functioning as an outcome measure in schizophrenia studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Methamphetamine use and schizophrenia: a population-based cohort study in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Conducting efficient literature searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The assessment of insight in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The course, treatment, and outcome of substance disorder in persons with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A meta-analytic review of psychosocial interventions for substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Imputing missing standard deviations in meta-analyses can provide accurate results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Revising axis V for DSM-IV: a review of measures of social functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Selecting a rating scale for evaluating services to the chronically mentally ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Reasons for increased substance use in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cognitive behaviour therapy for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Treatment of substance abusing patients with comorbid psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Neurocircuitry of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Exploration of the comorbidity of alcohol use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Assessment of client/patient satisfaction: development of a general scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Clinical implications of Brief Psychiatric Rating Scale scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

What does the PANSS mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The British experience of dual diagnosis in the national health service.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Treating comorbid substance use disorders in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Development of a schizophrenia scale sensitive to change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Clinical interventions for severe mental illness and co-occurring substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Treatment of dual diagnosis disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Application and results of the Manchester Short Assessment of Quality of Life (MANSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Cognitive behavioral therapy for schizophrenia: an empirical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The impact of substance use disorders on the course of schizophrenia--a 15-year follow-up study: dual diagnosis over 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Defining dual diagnosis of mental illness and substance misuse: some methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

The reliability and validity of the SAS-SMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Psychosocial interventions for people with both severe mental illness and substance misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Nidotherapy in the treatment of substance misuse, psychosis and personality disorder: secondary analysis of a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Treatment for the Dually Diagnosed Homeless

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Interpreting Results and Drawing Conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Case management for people with severe mental disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Cognitive behaviour therapy for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Treatment programmes for people with both severe mental illness and substance misuse

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Cost-effective treatment for persons with dual disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

[State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Reliability and validity of a depression rating scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Role of self-help processes in achieving abstinence among dually diagnosed persons.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Social class, psychological disorder, and the nature of the psychopathologic indicator

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Screening depressed patients in family practice. A rapid technic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Cognitive behavior therapy for schizophrenia in patients with mild to moderate substance misuse problems

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Effects of cocaine on hospital course in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Treatment of substance abuse in severely mentally ill patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Schizophrenia and co-occurring substance use disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A peer-support, group intervention to reduce substance use and criminality among persons with severe mental illness.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Integrated Care for Co-occurring Disorders: Psychiatric Symptoms, Social Functioning, and Service Costs at 18 Months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Motivational interviewing and clinical psychiatry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Rehabilitation during alcohol detoxication in comorbid neuropsychiatric patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

Adding contingency management intervention to vocational rehabilitation: outcomes for dually diagnosed veterans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

A review of comorbidity: major mental illness and problematic substance use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB3

7 January 2021

10.1002/14651858.CD001088.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24092525

1 reference

Consolidated OpenCitations Corpus – April 2017